The contribution of imaging genetics to the development of predictive markers for addictions

Trends in Cognitive Sciences

Volumn 15, Issue 9, 2011, Pages 436-446

  Loth, Eva ^a   Carvalho, Fabiana ^a   Schumann, Gunter ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL NETWORKS; BRAIN ACTIVATION; BRAIN FUNCTIONS; EARLY DIAGNOSIS; ENVIRONMENTAL FACTORS; GENETIC STUDIES; INDIVIDUAL VARIABILITY; REGIONS OF INTEREST; RISK PROFILE;

REINFORCEMENT;

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; OXYTOCIN RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN TRANSPORTER;

ADDICTION; ADOLESCENT HEALTH; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; BDNF GENE; COMT GENE; COPY NUMBER VARIATION; CORPUS STRIATUM; DRD 2 GENE; DRD 4 GENE; EMOTION; EXECUTIVE FUNCTION; GENE; GENE INTERACTION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INFERIOR FRONTAL GYRUS; MAOA GENE; NEUROIMAGING; NONHUMAN; NPY GENE; PREDICTION; PREFRONTAL CORTEX; PREMOTOR CORTEX; REINFORCEMENT; REVIEW; REWARD; SINGLE NUCLEOTIDE POLYMORPHISM; SLC 6A3 GENE; SLC 6A4 GENE; SUPPLEMENTARY MOTOR AREA; TASK PERFORMANCE; VARIABLE NUMBER OF TANDEM REPEAT;

BIOLOGICAL MARKERS; BRAIN; COGNITION DISORDERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIVIDUALITY; INHIBITION (PSYCHOLOGY); NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; REINFORCEMENT (PSYCHOLOGY); RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 80051915934     PISSN: 13646613     EISSN: 1879307X     Source Type: Journal    
DOI: 10.1016/j.tics.2011.07.008     Document Type: Review

References (101)

1. Goldman D., et al. The genetics of addictions: uncovering the genes. Nat. Rev. Genet. 2005, 6:521-532.
2. Chambers R.A., et al. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am. J. Psychiatry 2003, 160:1041-1052.
3. Taioli E., Wynder E.L. Effect of the age at which smoking begins on frequency of smoking in adulthood. N. Engl. J. Med. 1991, 325:968-969.
4. O'Brien M.S., Anthony J.C. Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001. Neuropsychopharmacology 2005, 30:1006-1018.
5. Goodman A. Neurobiology of addiction: An integrative review. Biochemical. Pharmacol. 2008, 75:266-322.
6. Caspi A., et al. Behavioral observations at age 3 years predict adult psychiatric disorders: Longitudinal evidence from a birth cohort. Arch. Gen. Psychiatry 1996, 53:1033-1039.
7. Hamer D. Rethinking behavior genetics. Science 2002, 298:71.
8. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 2006, 7:818-827.
9. Somerville L.H., et al. A time of change: Behavioural and neural correlates of adolescent sensitivity to appetitive and aversive environmental cues. Brain Cogn. 2010, 72:124-133.
10. Barkley R.A. The executive functions and self-regulation: an evolutionary neuropsychological perspective. Neuropsychol. Rev. 2001, 11:1-29.
11. Paus T., et al. Why do many psychiatric disorders emerge during adolescence?. Nat. Rev. Neurosci. 2008, 9:947-957.
12. Giedd J.N., et al. Anatomic Magnetic Resonance Imaging of the Developing Child and Adolescent Brain and Effects of Genetic Variation. Neuropsychol. Rev. 2010, 20:349-361.
13. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005, 8:1458-1463.
14. Van Leijenhorst L., et al. What motivates the adolescent? Brain regions mediating reward sensitivity across adolescence. Cerebr. Cortex 2010, 20:61-69.
15. Galvan A., et al. Earlier development of the accumbens relative to orbitofrontal cortex might underlie risk-taking behavior in adolescents. J. Neurosci. 2006, 26:6885-6892.
16. Bjork J.M., et al. Adolescents, adults and rewards: comparing motivational neurocircuitry recruitment using fMRI. PloS ONE 2010, 5:e11440.
17. Rubia K., et al. Progressive increase of frontostriatal brain activation from childhood to adulthood during event-related tasks of cognitive control. Hum. Brain Mapp. 2006, 27:973-993.
18. Nigg J.T., et al. Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders. J. Am. Acad. Child Adolesc. Psychiatry 2006, 45:468-475.
19. Shaw P., et al. Cortical development in typically developing children with symptoms of hyperactivity and impulsivity: support for a dimensional view of attention deficit hyperactivity disorder. Am. J. Psychiatry 2011, 168:143.
20. Shaw P., et al. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 2007, 64:921-931.
21. Schultz W. Potential Vulnerabilities of Neuronal Reward, Risk, and Decision Mechanisms to Addictive Drugs. Neuron 2011, 69:603-617.
22. Robbins T.W., Everitt B.J. Drug addiction: bad habits add up. Nature 1999, 398:567-570.
23. Volkow N.D., et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997, 386:830-833.
24. Volkow N.D., et al. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Psychiatry Res. 2002, 116:163-172.
25. Dalley J.W., et al. Nucleus accumens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
26. Robinson T.E., Berridge K.C. Incentive-sensitization and addiction. Addiction 2001, 2001:96.
27. Knutson B., et al. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 2001, 21:1-5.
28. Bjork J.M., et al. Incentive elicited striatal activation in adolescent children of alcoholics. Addiction 2008, 103:1308-1319.
29. Bjork J.M., et al. Incentive-elicited mesolimbic activation and externalizing symptomatology in adolescents. J. Child Psychol. Psychiatry 2010, 51:827-837.
30. Forbes E.E., et al. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol. Psychiatry 2009, 14:60-70.
31. Hariri A.R., et al. Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J. Neurosci. 2006, 26:13213-13217.
32. Bjork J.M., Smith A.R., Hommer D.W. Striatal sensitivity to reward deliveries and omissions in substance dependent patients. Neuoimage 2008, 42:1609-1621.
33. Yacubian J., et al. Gene-gene interaction associated with neural reward sensitivity. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:8125-8130.
34. Wrase J., et al. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 2007, 35:787-794.
35. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2009, 35:217-238.
36. Dreher J.C., et al. Variation in dopamine genes influences responsivity of the human reward system. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:617-622.
37. Schadt E.E. Molecular networks as sensors and drivers of common human diseases. Nature 2009, 461:218-223.
38. Chambers C.D., et al. Executive " brake failure" following deactivation of human frontal lobe. J. Cogn. Neurosci. 2006, 18:444-455.
39. Menon V., et al. Error-related brain activation during a Go/NoGo response inhibition task. Hum. Brain Mapp. 2001, 12:131-143.
40. Aron A.R., et al. Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI. J. Neurosci. 2007, 27:3743-3752.
41. Li C.R., et al. Altered impulse control in alcohol dependence: neural measures of stop signal performance. Alcohol. Clin. Exp. Res. 2009, 33:740-750.
42. Schachar R., et al. Restraint and cancellation: multiple inhibition deficits in attention deficit hyperactivity disorder. J. Abnorm. Child Psychol. 2007, 35:229-238.
43. Horne M., et al. Long-term administration of cocaine or serotonin reuptake inhibitors results in anatomical ad neurochemical changes in noradrenergic, dopaminergic, and serotonin pathways. J. Neurochem. 2008, 106:1731-1744.
44. Eagle D.M., et al. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl.) 2008, 199:439-456.
45. Dalley J.W., et al. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011, 69:680-694.
46. Rubia K., et al. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. Am. J. Psychiatry 2005, 162:1067-1075.
47. 11C] Methyl-L-Tryptophan trapping in impulsive subjects with borderline personality disorder. Am. J. Psychiatry 2001, 158:775.
48. Van den Bergh F., et al. Relationship of delay aversion and response inhibition to extinction learning, aggression, and sexual behaviour. Behav. Brain Res. 2006, 175:75-81.
49. Bevilacqua L., et al. A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature 2010, 468:1061-1066.
50. Munafò M., et al. Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data. Biol. Psychiatry 2008, 63:197-206.
51. Congdon E., et al. Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:27-32. (in eng).
52. Laucht M., et al. Novelty seeking involved in mediating the association between the dopamine D4 receptor gene exon III polymorphism and heavy drinking in male adolescents: results from a high-risk community sample. Biol. Psychiatry 2007, 61:87-92.
53. Meyer-Lindenberg A., et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6269-6274.
54. Passamonti L., et al. Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol. Psychiatry 2006, 59:334-340.
55. Braet W., et al. fMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHD. Neuropsychologia 2011, 49:1641-1650.
56. Filbey F.M., et al. Dopaminergic genes modulate response inhibition in alcohol abusing adults. Addiction Biol. 2011, 10.1111/j.1369-1600.2011.00328.
57. Congdon E., et al. Influence of SLC6A3 and COMT variation on neural activation during response inhibition. Biological. Psychol. 2009, 81:144-152.
58. Clark L., et al. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology 2005, 182:570-578.
59. Sterzer P., Stadler C. Neuroimaging of aggressive and violent behaviour in children and adolescents. Front Behav. Neurosci. 2009, 3:35.
60. Pilowsky D.J., et al. Adverse childhood events and lifetime alcohol dependence. Am. J. Pub. Health 2009, 99:258.
61. Rutter M Gene-environment interdependence. Dev. Sci. 2007, 10:12-18.
62. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
63. Karst H., et al. Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers. Nat. Neurosci. 2000, 3:977-978.
64. LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol. Neurobiol. 2003, 23:727-738.
65. Beesdo K., et al. Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. Arch. Gen. Psychiatry 2009, 66:275-285. (in eng).
66. Bishop S., et al. Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nat. Neurosci. 2004, 7:184-188.
67. Treutlein J., et al. Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol. Psychiatry 2006, 11:594-602.
68. Blomeyer D., et al. Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biol. Psychiatry 2008, 63:146-151.
69. Zhang H., et al. Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family-and population-based studies. Biol. Psychiatry 2009, 66:128-136.
70. Desrivières S., et al. Glucocorticoid receptor (NR3C1) gene polymorphisms and onset of alcohol abuse in adolescents. Addict. Biol. 2011, 16:510-513.
71. Clarke T.K., et al. Multiple polymorphisms in genes of the adrenergic stress system confer vulnerability to alcohol abuse. Addict. Biol. 2010, 10.1111/j.1369-1600.2010.00263.
72. Clarke T.K., et al. KCNJ6 is associated with adult alcohol dependence and involved in gene × early life stress interactions in adolescent alcohol drinking. Neuropsychopharmacology 2011, 36:1142-1148.
73. Dong, L, et al. (2011) The circadian rhythm gene Period1 is associated with psychosocial stress-induced alcohol drinking Am. J. Psychiatry (in press).
74. Lesch K.P., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
75. Caspi A., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
76. Karg K., et al. The serotonin transporter promoter variant (5-HTTLPR), stress and depression meta-analysis revisited. Arch. Gen. Psychiatry 2011, 68:444-454.
77. Kaufman J., et al. Genetic and environmental predictors of early alcohol use. Biol. Psychiatry 2007, 61:1228-1234.
78. Hariri A.R., et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
79. Heinz A., et al. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 2004, 8:20-21.
80. Pezawas L., et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8:828-834.
81. Smolka M., et al. Gene-gene effects on central processing of aversive stimuli. Mol. Psychiatry 2007, 12:307-317.
82. Berton O., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
83. Colzato L., et al. BDNF Val (66) Met polymorphism is associated with higher anticipatory cortisol stress response, anxiety, and alcohol consumption in healthy adults. Psychoneuroendocrinology 2011, 10.1016/j.psyneuen.2011.04.010.
84. Lau J.Y.F., et al. BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents. Neuroimage 2010, 53:952-961.
85. Pandey S.C. Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol. Sci. 2003, 24:456-460.
86. Zhou Z., et al. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.
87. Burnett S., et al. The social brain in adolescence: Evidence from functional magnetic resonance imaging and behavioural studies. Neurosci. Biobeh. Rev. 2011, 35:1654-1664.
88. Grosbras M.-H., et al. Neural mechanisms of resistance to peer influence in early adolescence. J. Neurosci. 2007, 27:8040-8045.
89. Insel T.R. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 2010, 65:768-779.
90. Chein J., et al. Peers increase adolescent risk taking by enhancing activity in the brain's reward circuitry. Dev. Sci. 2010, 14:F1-F10.
91. Guyer A.E., et al. Amygdala and ventrolateral prefrontal cortex function during anticipated peer evaluation in pediatric social anxiety. Arch. Gen. Psychiatry 2008, 65:1303-1312.
92. Edwards S., et al. Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol dependent rats. Addiction Biol. 2011, 10.1111/j.1369-1600.2010.00291.
93. Tost H., et al. A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proc. Natl. Acad. Sci. 2010, 107:13936-13941.
94. Stein L., et al. Voxelwise genome-wide association study (vGWAS). Neuroimage 2010, 53:1160-1174.
95. Calhoun V.D., et al. A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data. Neuroimage 2009, 45:S163-S172.
96. Bullmore E., Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009, 10:186-198.
97. Voineagu I., et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
98. Geschwind D.H., Konopka G. Neuroscience in the era of functional genomics and systems biology. Nature 2009, 461:908-915.
99. Zhang D., et al. Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 2011, 55:856-867.
100. Biswal B.B., et al. Toward discovery science of human brain function. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4735-4739.
101. Schumann G., et al. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol. Psychiatry 2010, 15:1128-1139.